Explain the formation of ATP in electron transport chain with diagram, mention ATP synthesis sites and inhibitors of ETC uncoupled of etc components of respiratory chain

Reading File
Finding Sources
Finding Sources
Searching Images

electron transport chain ATP synthesis mitochondria diagram

Reading File
Reading File
Finding Sources
Loading Image
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Loading Image
Loading Image
Loading Image
Reading File
I have all the content needed for a comprehensive answer. Let me now compose the full response:

Electron Transport Chain (ETC) & ATP Synthesis

Overview

Energy-rich molecules (glucose, fatty acids, amino acids) are oxidized through metabolic pathways (glycolysis, β-oxidation, TCA cycle) to generate NADH and FADH₂. These reduced coenzymes donate electrons to the ETC, releasing energy that is captured as ATP. This coupling of electron transport to ATP synthesis is called oxidative phosphorylation (OXPHOS).

Diagram 1 — Components of the Respiratory Chain

ETC Components — Complexes I–IV with CoQ and Cytochrome c
Components of the electron transport chain showing NADH:CoQ oxidoreductase (Complex I), Succinate dehydrogenase (Complex II), Cytochrome b-c₁ complex (Complex III), and Cytochrome c oxidase (Complex IV). — Basic Medical Biochemistry, 6e

Components of the Respiratory Chain (Complexes I–IV)

ComplexNameProsthetic GroupsElectrons FromProtons Pumped
INADH:CoQ oxidoreductase (NADH dehydrogenase)FMN, Fe-S centersNADH → CoQ4 H⁺
IISuccinate:CoQ oxidoreductase (Succinate dehydrogenase)FAD, Fe-S centersFADH₂ → CoQ0 H⁺
IIICoQH₂:Cytochrome c oxidoreductase (Cytochrome bc₁)Cyt b, Fe-S, Cyt c₁CoQ → Cyt c4 H⁺
IVCytochrome c oxidaseCyt a, Cyt a₃, CuA, CuBCyt c → O₂ → H₂O2 H⁺
VATP synthase (F₁F₀-ATPase)H⁺ gradient → ATP
Mobile carriers (not fixed in complexes):
  • Coenzyme Q (CoQ / Ubiquinone): Lipid-soluble; shuttles electrons from Complex I and II (and glycerol-3-phosphate dehydrogenase, acyl-CoA dehydrogenase) to Complex III
  • Cytochrome c: Water-soluble; peripheral to the inner mitochondrial membrane; shuttles electrons from Complex III to Complex IV

Diagram 2 — ETC with Proton Pumping & ATP Synthesis

ETC with proton pumping and ATP synthesis via Complex V
ETC showing proton pumping at Complexes I (4H⁺), III (4H⁺), and IV (2H⁺). Ten H⁺ are pumped per NADH oxidized. Complex V (ATP synthase) uses the gradient to synthesize ATP. — Lippincott Illustrated Reviews: Biochemistry, 8e

ATP Formation — Chemiosmotic Hypothesis (Mitchell Hypothesis)

Mechanism

  1. Proton pump: As electrons pass through Complexes I, III, and IV, energy released drives pumping of H⁺ from the matrix to the intermembrane space (IMS).
    • 10 H⁺ pumped per NADH oxidized (4+4+2)
    • 6 H⁺ pumped per FADH₂ oxidized (0+4+2, entering via CoQ)
  2. Electrochemical gradient (Proton-Motive Force): This creates:
    • An electrical gradient (positive charge accumulates in IMS)
    • A pH gradient (IMS is more acidic than matrix)
    • Together = proton-motive force (~220 mV)
  3. ATP synthase (Complex V): H⁺ re-enter the matrix through the F₀ channel, driving rotation of the c-ring. This rotational energy is transmitted to the F₁ domain, where conformational changes in the three β subunits cyclically:
    • Bind ADP + Pᵢ
    • Catalyze phosphorylation (ATP synthesis)
    • Release ATP
    • One full rotation = 3 ATP; ~3–4 H⁺ needed per ATP

Binding Change Mechanism (Boyer)

The three β subunits exist in three conformational states (open "O", loose "L", tight "T") that rotate with each H⁺ flux. ADP + Pᵢ bind at the open site; ATP is spontaneously synthesized at the tight site; and pre-formed ATP is released as the site becomes open again.

ATP Synthesis Sites

SiteATP Yield per Mole
NADH → Complex V (via I, III, IV)~2.5 ATP
FADH₂ → Complex V (via II, III, IV)~1.5 ATP
Substrate-level phosphorylation (TCA — succinyl-CoA synthetase)1 GTP/ATP
Substrate-level phosphorylation (Glycolysis — PGK, PK)2 ATP net
Total ATP from complete glucose oxidation:
  • Glycolysis: ~2 ATP (net) + 2 NADH (cytosolic)
  • Pyruvate decarboxylation: 2 NADH
  • TCA cycle: 6 NADH + 2 FADH₂ + 2 GTP
  • Grand total: ~30–32 ATP per glucose

Diagram 3 — Full ETC with ROS Generation

Full ETC with Complexes I–V and ROS pathways
Full ETC showing electron flow, proton pumping, ATP export via VDAC, and superoxide (O₂•⁻) generation at Complexes I and III

Inhibitors of the ETC

A. ETC Electron Transport Inhibitors (Block specific complexes)

InhibitorSite of ActionMechanismClinical/Toxicological Significance
RotenoneComplex IBlocks NADH → CoQ electron transferPesticide/insecticide; used in Parkinson's research
Amobarbital (Amytal)Complex IBlocks FMN/Fe-S regionBarbiturate toxicity
TTFA (Thenoyltrifluoroacetone)Complex IIBlocks Fe-S centersExperimental inhibitor
Antimycin AComplex IIIBlocks Cyt b → Cyt c₁ (inhibits Q cycle)Fungicide; fish poison
BAL (Dimercaprol)Complex IIIChelates Fe-S centersAlso used as chelation therapy
CO (Carbon monoxide)Complex IVBinds Cyt a₃, blocks O₂ bindingLethal poisoning; binds with high affinity
Cyanide (CN⁻)Complex IVBinds Fe³⁺ of Cyt a₃Used in chemical warfare; treated with hydroxocobalamin/thiosulfate
Hydrogen sulfide (H₂S)Complex IVSimilar to CN⁻Sewer gas poisoning
Azide (N₃⁻)Complex IVBinds Cyt a₃Laboratory ETC inhibitor
Effect of ETC inhibitors: Electron flow stops → H⁺ pumping stops → proton-motive force collapses → ATP synthesis stops → NADH and FADH₂ accumulate → O₂ consumption decreases.

B. ATP Synthase (Phosphorylation) Inhibitors

InhibitorMechanism
OligomycinBinds F₀ domain; blocks H⁺ channel → stops proton re-entry → electron transport also stops (respiratory control)
AurovertinBinds F₁ domain; inhibits ATP synthesis
Dicyclohexylcarbodiimide (DCCD)Reacts covalently with F₀; blocks proton channel

C. Uncouplers of Oxidative Phosphorylation

Uncouplers dissipate the proton gradient without going through ATP synthase. Electron transport continues (or accelerates), but energy is released as heat instead of ATP.
UncouplerTypeMechanism
2,4-Dinitrophenol (DNP)Synthetic (lipophilic ionophore)Shuttles H⁺ across inner membrane, bypassing F₀
CCCP (Carbonyl cyanide m-chlorophenylhydrazone)SyntheticProtonophore; causes uncoupling
Thermogenin / UCP1Endogenous (brown fat)H⁺ channel in inner mitochondrial membrane; non-shivering thermogenesis in neonates; activated by cold via catecholamines
UCP2, UCP3Endogenous (other tissues)Role in heat production, regulation of ROS
Aspirin (salicylates) — high doseDrugUncouples OXPHOS; mechanism of fever in overdose
Long-chain fatty acidsEndogenousAct as protonophores; can be returned to normal by albumin
Key feature of uncouplers: O₂ consumption increases (electron transport uninhibited) but ATP synthesis decreases. Body temperature rises (energy released as heat). Weight loss occurs as more fuel is burned without ATP production — the historical basis for DNP's brief use as a diet drug (abandoned due to fatal hyperthermia).

Respiratory Control

In tightly coupled mitochondria, electron transport rate is controlled by ADP availability:
  • High ADP → faster electron transport, more O₂ consumption, more ATP synthesis
  • Low ADP → electron transport slows (rate-limiting step is H⁺ re-entry through ATP synthase)
  • Oligomycin locks mitochondria in a state of low electron transport despite adequate substrate

Summary: Sites of Action

NADH → [Complex I] → CoQ ← [Complex II] ← FADH₂
                              ↓
                    [Complex III] → Cyt c
                                        ↓
                              [Complex IV] → H₂O
                                    ↓
                         H⁺ gradient (proton-motive force)
                                    ↓
                           [Complex V / ATP Synthase]
                                    ↓
                                  ATP

Inhibitors:          Uncouplers:
 I  — Rotenone       DNP, Thermogenin (UCP1)
 III — Antimycin A   Salicylates (high dose)
 IV — CN⁻, CO, N₃⁻
 V  — Oligomycin

Sources:
  • Lippincott Illustrated Reviews: Biochemistry, 8th ed. pp. 224–243
  • Basic Medical Biochemistry: A Clinical Approach, 6e. pp. 860–878
This is a shared conversation. Sign in to Orris to start your own chat.